Rafael Holdings: Phase 3 LPLV complete; NDA submission and topline expected 2H 2026TradingView·Jul 8 at 03:53 PMRFL+0.39%
U.S. stock intraday update: Rafael-B down 7.94%, trading volume increases with active funds, sector trend volatility intensifiesPrice Alert·Jul 6 at 01:32 PMRFL+0.39%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jun 17 at 04:06 PMADTX+10.29%NRSN+1.50%
Rafael Holdings shares are trading higher. The company reported Q3 financial results.benzinga_article·Jun 11 at 12:28 PMRFL+0.39%
Rafael Holdings, Inc. 3Q 2026: Revenue $179K, EPS ($0.08) — 10-Q SummaryTradingView·Jun 11 at 07:21 AMRFL+0.39%
Rafael Holdings reports Q3 FY2026 net loss of $4.2M; cash $30.5M; NDA expected H2 2026TradingView·Jun 11 at 07:03 AMRFL+0.39%
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results | RFL Stock NewsStockTitan·Jun 10 at 10:30 PMRFL+0.39%
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C | RFL Stock NewsStockTitan·Jun 9 at 10:30 PMRFL+0.39%
